Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression

Launched by FONDAZIONE IRCCS CA' GRANDA, OSPEDALE MAGGIORE POLICLINICO · Feb 27, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating how obesity can affect the progression of prostate cancer. Specifically, researchers want to understand the role of certain proteins involved in the production and movement of a substance called lactate, which may influence cancer growth. They will compare tissue samples from men with prostate cancer who are severely overweight to those who are at a healthier weight. The study also aims to look at how the immune system interacts with these cancer cells in different patients.

To be eligible for this trial, participants must be male and diagnosed with prostate cancer. The study is currently recruiting men aged 65 to 74 who meet these criteria. If you join the trial, you can expect to provide tissue samples for analysis and to help researchers learn more about how obesity may change the way prostate cancer develops and responds to treatment. This could ultimately contribute to better understanding and management of the disease in overweight patients.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • affected by prostate cancer
• Exclusion Criteria:
• • -